Schafer Carol

Schafer Carol is listed in filings as Director at Kura Oncology, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including 8 public disclosures. Recent filings connect the profile to Kura Oncology, Inc. (KURA), Insmed Incorporated (INSM), Repare Therapeutics Inc. (RPTX), and Immunome, Inc. (IMNM). The current snapshot covers public activity from Jun 18, 2024 to Jun 4, 2026. Reported amounts are shown as $306.9K to $17.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.